Ryvu Therapeutics SA (RVU) — Capital Reinvestment Ratio
Ryvu Therapeutics SA (RVU) has a Capital Reinvestment Ratio of 0.07x as of December 2022, meaning it reinvests 0% of its operating cash flow (zł59.92 Million) in capital expenditures (zł4.22 Million). See RVU net asset quality score to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Ryvu Therapeutics SA Capital Reinvestment Ratio (2017–2022)
This chart tracks Ryvu Therapeutics SA's Capital Reinvestment Ratio across 2 annual periods. Check RVU cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Ryvu Therapeutics SA (2017–2022)
Year-by-year Capital Reinvestment Ratio for Ryvu Therapeutics SA from 2017 to 2022. For live market cap and broader valuation context, see Ryvu Therapeutics SA (RVU) total market value.
| Year | Reinvestment Ratio | Operating CF (PLN) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.44x | zł21.32 Million | zł9.29 Million | ▼ -77.8% |
| 2017 | 1.96x | zł10.98 Million | zł21.56 Million | — |